Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
about
Chemotherapy for hormone-refractory prostate cancer: beauty is in the eye of the beholder.Evidence of a dual role of endogenous histamine in angiogenesis.Can the clinical course of cancer be influenced by non-antineoplastic drugs?N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer.Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer.Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell lines.Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.Degradation of the 74 kDa form of L-histidine decarboxylase via the ubiquitin-proteasome pathway in a rat basophilic/mast cell line (RBL-2H3).Parameters affecting the ex vivo cytotoxic drug sensitivity of human hematopoietic cells.
P2860
Q34057806-86C6DFE3-6058-4B7D-BD15-E3956BFC9055Q34294072-596E0C5A-A18B-4777-A24A-17330BC9CB66Q34710426-073D4C3C-6483-43B2-B601-A94120657D8EQ34778630-68671111-5402-446C-AD06-1B69FA2A36C8Q36677464-8EE768AC-4DF3-4BF8-B13E-C7A744A90962Q38860029-C8F2D70E-9F79-4590-BE53-7945D6CC7DD5Q39202160-4F4AD936-CB29-4DEA-8081-F2BCB7CBAFCDQ41073999-4DB6332F-F5A7-49DC-B27A-1D6921C95B9BQ41077300-BFE2684A-41D0-4205-9B1D-3A2590AFA3BFQ53951493-EEB4C7A6-FBB6-48C4-ACFB-BC0D6B884575
P2860
Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Increased therapeutic index of ...... ellular histamine antagonists.
@en
Increased therapeutic index of ...... ellular histamine antagonists.
@nl
type
label
Increased therapeutic index of ...... ellular histamine antagonists.
@en
Increased therapeutic index of ...... ellular histamine antagonists.
@nl
prefLabel
Increased therapeutic index of ...... ellular histamine antagonists.
@en
Increased therapeutic index of ...... ellular histamine antagonists.
@nl
P2093
P356
P1476
Increased therapeutic index of ...... ellular histamine antagonists.
@en
P2093
Brandes LJ
LaBella FS
Warrington RC
P304
P356
10.1093/JNCI/83.18.1329
P407
P577
1991-09-01T00:00:00Z